OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

4 Projects | 1 Researchers | $532,067 Invested

2010

Brigham and Women's Hospital

Michael Wolfe, PhD

Targeting the Tau Message for Dementia

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2008

Brigham and Women's Hospital

Michael Wolfe, PhD

Selective Amyloid-Lowering Agents: Year 2

  • Funding Amount: $130,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2006

Brigham and Women's Hospital

Michael Wolfe, PhD

Selective Amyloid-Lowering Agents

  • Funding Amount: $130,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2000

Brigham and Women's Hospital

Michael Wolfe, PhD

Helical Peptidomimetics as Inhibitors of Alzheimer's Gamma-Secretase

  • Funding Amount: $147,067
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed